HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Acetyl L-carnitine (ALC) treatment in elderly patients with fatigue.

Abstract
Fatigue is one of the conditions most frequently complained by the elderly. There are few effective treatment options for patients with chronic fatigue syndrome. To determine the efficacy, tolerability and impact on the fatigue, as well as on cognitive and functional status of elderly subjects with acetyl L-carnitine (ALC), 96 aged subjects (>70 years, range 71-88) were investigated (50 females and 46 males; mean age 76.2+/-7.6 and 78.4+/-6.4 years, respectively). They met four or more of the Holmes major criteria or at least six of Fukuda minor criteria. Fatigue was measured with the Wessely and Powell [Wessely, S., Powell, R., 1989. Fatigue syndromes: a comparison of chronic postviral fatigue with neuromuscular and affective disorders. J. Neurol. Neurosurg. Psychiatry 52, 940-948] scores, with the fatigue severity scale. At the end of the treatment, we observed a decrease of physical fatigue: 6.2 (p<0.001), of mental fatigue: 2.8 (p<0.001), of severity fatigue: 21.0 (p<0.001) and improvements in functional status: 16.1 (p<0.001) and cognitive functions: 2.7 (p<0.001). By the end of the treatment, significant differences between the two groups were found for the following parameters: muscle pain -27% versus -3% (p<0.05); prolonged fatigue after exercise: 51% versus -4% (p<0.0001); sleep disorders: 28% versus 4% (p<0.05); physical fatigue: 7 versus -0.5 (p<0.0001); mental fatigue: -3.3 versus 0.6 (p<0.0001); fatigue severity scale: -22.5 versus 1.2 (p<0.0001); functional status 17.1 versus 0.6 (p<0.0001); mini mental state examination (MMSE) improvements: 3.4 versus 0.5 (p<0.0001). Our data show that administering ALC may reduce both physical and mental fatigue in elderly and improves both the cognitive status and physical functions.
AuthorsMichele Malaguarnera, Maria Pia Gargante, Erika Cristaldi, Valentina Colonna, Masa Messano, Aleardo Koverech, Sergio Neri, Marco Vacante, Lisa Cammalleri, Massimo Motta
JournalArchives of gerontology and geriatrics (Arch Gerontol Geriatr) 2008 Mar-Apr Vol. 46 Issue 2 Pg. 181-90 ISSN: 0167-4943 [Print] Netherlands
PMID17658628 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Nootropic Agents
  • Acetylcarnitine
Topics
  • Acetylcarnitine (administration & dosage, therapeutic use)
  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Cognition (drug effects, physiology)
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Fatigue Syndrome, Chronic (drug therapy, physiopathology, psychology)
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Motor Activity (drug effects, physiology)
  • Nootropic Agents (administration & dosage, therapeutic use)
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: